FAST Study – Neuroprogressive and Dementia Network

Feasibility and Acceptability of Scalable Tests

The Feasibility and Acceptability of Scalable Tests (FAST) study is a pilot study led by the University of Oxford, alongside Dementias Platform UK. It looks at dementia risk screening using digital assessments and blood tests. More information can be found here.

This study is in setup

To find out more about this research study, please contact:
loth.sdcrn@nhs.scot
0131 537 3804

Key Staff

NDN Principal Investigator: Jessica Crossan

NDN Study Lead: Marian Montanha

This is looking at patients with Alzheimer’s Disease and healthy individuals.

CONTACT INFORMATION

Neuroprogressive & Dementia Research Network Office

Old Pharmacy Building
Western General Hospital
Edinburgh
EH4 2XU

Email: loth.sdcrn@nhs.scot

Telephone: 0131 537 3804

ABOUT US

The NRS Neuroprogressive Disease and Dementia Network team in NHS Lothian conduct commercial and investigator led studies for: Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, Motor Neurone Disease, dementia with Lewy bodies, Progressive Supranuclear Palsy and Multiple System Atrophy.